Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(75 sites)
United States
Alta Bates Summit Medical Center, Berkeley, California City of Hope Cancer Center, Duarte, California University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica, California Yale Cancer Center, New Haven, Connecticut Georgetown University, Washington D.C., District of Columbia University of Miami, Coral Gables, Florida Indiana University, Indianapolis, Indiana University of Michigan Health System, Ann Arbor, Michigan St. Luke's Hospital, Chesterfield, Missouri Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey University of Rochester, Rochester, New York Medical University of S. Carolina, Charleston, South Carolina Avera Cancer Institute, Sioux Falls, South Dakota Renovatio Clinical - El Paso, El Paso, Texas Renovatio Clinical, The Woodlands, Texas University of Virginia, Charlottesville, Virginia West Virginia University, Morgantown, West Virginia Australia
Calvary Mater Newcastle, Waratah, New South Wales Royal Adelaide Hospital, Adelaide, South Australia Epworth Hospital, Richmond, Victoria Brazil
Hospital Sao Rafael - HSR, Salvador, Estado de Bahia ICTR Curitiba, Curitiba, Paraná Hospital Mae de Deus, Porto Alegre, Rio Grande do Sul Hospital Paulistano, São Paulo, São Paulo Hospital Alemao Oswaldo Cruz, São Paulo, São Paulo Hospital A. C. Camargo, São Paulo, São Paulo Instituto D'Or Pesquisa e Ensino, São Paulo, São Paulo Americas Medical City, Rio de Janeiro Beneficencia Portuguesa de Sao Paulo, São Paulo Canada
Victoria Hospital - London Health Sciences Centre, London, Ontario The Ottawa Hospital - General Campus, Ottawa, Ontario Princess Margaret Cancer Center, Toronto, Ontario China
Beijing Tong Ren Hospital, Capital Medical University, Beijing The First Hospital of Jilin University, Changchun West China Hospital of Sichuan University, Chengdu Chongqing Cancer Hospital, Chongqing Fujian Provincial Cancer Hospital, Fuzhou Sun yat-sen University Cancer Center, Guangzhou Guangxi Cancer Hospital of Guangxi Medical University, Nanning Fudan University Shanghai Cancer Center, Shanghai The First Affiliated Hospital of China Medical University, Shenyang The First Affiliated Hospital of Wenzhou Medical University, Wenzhou The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan Cancer Hospital, Zhengzhou France
Hopital Claude Huriez, Lille Hopital Saint Eloi, Montpellier CHU NANTES - Hôtel Dieu, Nantes INSTITUT CURIE_SITE PARIS - Service d'Oncologie Médicale., Paris Italy
Policlinico S.Orsola-Malpighi, Bologna, Emilia-Romagna Humanitas Gavazzeni, Bergamo, Lombardy Irccs Istituto Europeo Di Oncologia (IEO), Milan, Lombardy SC Ematologia, AO SS. Antonio e Biagio e C. Arrigo, Alessandria, Piedmont A.O. Città della Salute e della Scienza D - Osp. S. Giov. Battista Molinette, Turin, Piedmont Puerto Rico
Auxilio Mutuo Cancer Center, San Juan South Korea
Chungnam National University Hospital, Daejeon Severance Hospital, Yonsei University Health System, Seoul Seoul National University Hospital, Seoul Asan Medical Center, Seoul Samsung Medical Center, Seoul Spain
Hospital Universitario Puerta del Mar, Cadiz, Cadiz Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña Hospital Universitari Vall d'Hebron, Barcelona Hospital Clinic de Barcelona, Barcelona Hospital General Universitario J.M Morales Meseguer, Murcia Sweden
Skånes University Hospital, Skånes Department of Onclology, Lund Akademiska sjukhuset, Onkologkliniken, Uppsala Taiwan
National Taiwan Universtiy Hospital, Taipei Chang Gung Medical Foundation - Linkou, Taoyuan District United Kingdom
NHS Greater Glasgow and Clyde, Glasgow Lincolnshire County Hospital, Lincoln University College London Hospital, London Christie Hospital Nhs Trust, Manchester Oxford Churchill Hospital, Oxford Derriford Hospital, Plymouth